Obstetrics/Gynecology
RSSArticles
-
Pharmacology Watch: Estrogen Found to Not Affect Heart Disease, Breast Cancer
The NIH has halted the estrogen-alone wing of the Womens Health Initiative a year before its scheduled end. -
Clinical Briefs
Migraine and Subclinical Brain Lesions; Memantine Treatment in Alzheimer Disease; PPG in Type 2 DM -
Pharmacology Update: Bevacizumab Injection (Avastin)
The FDA has approved the first antineoplastic that acts by the inhibiting the formation of new blood vessels in tumors. -
What’s Best for the Breast?
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way. -
Full February 15, 2004, Issue in PDF
-
Clinical Briefs
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera; Coronary Artery Calcium Score Plus Framingham Score for Risk Prediction; Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis -
Pharmacology Update: Olanzapine and Fluoxetine Capsules (Symbyax — Lilly)
The FDA has approved a combination of olanzapine and fluoxetine for the treatment of depressive episodes associated with bipolar disorder. -
Another Tool for a Common Problem
Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis. -
Clinical Briefs in Primary Care Supplement
Sulfonamide Antibiotics and Sulfonamide Nonantibiotics; Autoantibodies Before Onset of SLE; Prevention of VTE with Ximelagatran; Combined Levothyroxine Plus Liothyronine Compared to Levothyroxine Alone in Primary Hypothyroidism; Specific Site Involvement in Fixed Drug Eruption; Anticoagulation Therapy for Stroke Prevention in Patients with Atrial Fibrillation -
Full February 2004 Issue in PDF